Publications by authors named "A M Mayor"
Background: Rapid diagnostic tests (RDTs) based on the detection of Plasmodium falciparum histidine rich protein 2 (PfHRP2) are widely used for the diagnostic of P. falciparum in Africa. However, deletions of the pfhrp2 and pfhrp3 genes can lead to false negative test results and compromise appropriate case management.
View Article and Find Full Text PDFArticle Synopsis
- Maternal HIV and malaria infections during pregnancy can negatively impact the transfer of pertussis immunity from mothers to their infants.
- A study in Mozambique, involving 270 mother-infant pairs, found that mothers with HIV had significantly lower placental transfer of pertussis-specific antibodies compared to those without HIV.
- The findings suggest that addressing maternal HIV through healthcare interventions and immunization could help protect infants from pertussis.
Introduction: Malaria molecular surveillance has the potential to generate information on biological threats that compromise the effectiveness of antimalarial interventions. This study aims to streamline surveillance activities to inform the new strategic plan of the Mozambican National Malaria Control Programme (2023-2030) for malaria control and elimination.
Methods And Analyses: This prospective genomic surveillance study aims to generate genetic data to monitor diagnostic failures due to deletions and molecular markers of antimalarial drug resistance, to characterise transmission sources and to inform the implementation of new antimalarial approaches to be introduced in Mozambique (chemoprevention and child malaria vaccination).
This study presents the first clinical implementation of an efficient online daily adaptive proton therapy workflow (DAPT).The DAPT workflow includes awhere aand aare optimized on the planning computed tomography (CT). In the, theis re-optimized on daily images from an in-room CT.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to determine if selecting oral antiplatelet drugs based on a patient's genotype using a clinical decision support algorithm can lower the rate of major adverse cardiovascular and cerebrovascular events among Caribbean Hispanic patients following treatment.
- Conducted as an open-label, multicenter, non-randomized trial across eight hospitals in Puerto Rico, it involved 300 patients who received percutaneous coronary intervention and were divided into standard-of-care and genotype-guided groups.
- Results indicated that although the genotype-guided group had a lower risk of major adverse events compared to the standard group (8.7% vs 10.7%), the difference was not statistically significant.